Structural characteristics and refolding of in vivo aggregated hyperthermophilic archaeon proteins  by Umetsu, Mitsuo et al.
Structural characteristics and refolding of in vivo aggregated
hyperthermophilic archaeon proteins
Mitsuo Umetsua;b, Kouhei Tsumotoa;, Kumar Ashisha, Shigeki Nittaa, Yoshikazu Tanakaa,
Tadafumi Adschirib, Izumi Kumagaia;
aDepartment of Biomolecular Engineering, Graduate School of Engineering, Tohoku University, Aobayama 07, Aoba-ku, Sendai 980-8579, Japan
bInstitute of Multidisciplinary Research for Advanced Materials, Tohoku University, 2-1-1, Katahira, Aoba-ku, Sendai 980-8577, Japan
Received 3 November 2003; revised 26 November 2003; accepted 26 November 2003
First published online 15 December 2003
Edited by Thomas L. James
Abstract Several recombinant proteins in inclusion bodies ex-
pressed in Escherichia coli have been measured by Fourier
transform infrared and solid-state nuclear magnetic resonance
spectra to provide the secondary structural characteristics of the
proteins from hyperthermophilic archaeon Pyrococcus horikosh-
ii OT3 (hyperthermophilic proteins) in inclusion bodies. The
L-strand-rich single chain Fv fragment (scFv) and K-helix-rich
interleukin (IL)-4 lost part of the native-like secondary structure
in inclusion bodies, while the inclusion bodies composed of the
hyperthermophilic proteins of which the native form is K-helix
rich, are predominated by K-helix structure. Further, the sec-
ondary structure of the recombinant proteins solubilized from
inclusion bodies by detergent or denaturant was observed by
circular dichroism (CD) spectra. The solubilization induced
the denaturation of the secondary structure for scFv and IL-4,
whereas the solubilized hyperthermophilic proteins have retained
the K-helix structure with the CD properties resembling those of
their native forms. This indicates that the hyperthermophilic
proteins form native-like secondary structure in inclusion bodies.
Refolding of several hyperthermophilic proteins from in vivo
aggregated form without complete denaturation could be accom-
plished by solubilization with lower concentration (e.g. 2 M) of
guanidine hydrochloride and removal of the denaturant via step-
wise dialysis. This supports the existence of proteins with native-
like structure in inclusion bodies and suggests that non-native
association between the secondary structure elements leads to in
vivo aggregation. We propose a refolding procedure on the basis
of the structural properties of the aggregated archaeon proteins.
- 2003 Federation of European Biochemical Societies. Pub-
lished by Elsevier B.V. All rights reserved.
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1. Introduction
Bacterial expression of various foreign genes yields re-
combinant proteins in the periplasm or cytoplasm and also
in insoluble particles called inclusion bodies, which are often
formed in the bacterial host [1,2]. The in vivo aggregation is
recognized as a serious obstacle to utilizing the gene resources
supplied from genomic analysis. Completion of decoding
enormous genome sequences gave rise to the concept of struc-
tural genomics [3^5], which can supply various structures of
proteins only by expressing proteins as a soluble form. Inclu-
sion bodies are close-packed aggregates composed mainly of
the recombinant proteins and have no known physiological
function [6]. The aggregation of recombinant proteins may be
due partly to overexpression, which increases the local con-
centration of the protein, but several other factors also lead to
inclusion body formation; for example, non-native hydropho-
bic interactions among partially folded intermediates, reduc-
ing conditions in the cytoplasm, and intermolecular disul¢de
linking [7^10]. The in vivo aggregation of several proteins can
be suppressed by controlling culture conditions [11] and by
the coexpression of chaperone molecules [12,13]. However,
there is still little comprehensive understanding of the mech-
anism of inclusion body formation.
Despite the drawbacks of utilizing inclusion body forma-
tion, the refolding in vitro has been one of the primary topics
in protein engineering because no general system for inhibit-
ing the formation of inclusion bodies has been constructed
[14]. The recombinant protein solubilized by a high concen-
trated strong denaturant is refolded from a completely dena-
tured form by removal of the denaturants, however, it is fre-
quently di⁄cult to attain highly e⁄cient yield due to the
competing o¡-pathway self-association of the folding inter-
mediates in the refolding in vitro [15,16]. Recent studies on
unfolding and renaturation of protein supply several tech-
niques for inhibiting the aggregation; introduction of L-argi-
nine [15,17,18] or chaperone [19,20] in the system of removing
denaturants, and the refolding on column [21], but the e⁄-
cient yield in the refolding systems has been strongly depen-
dent upon the intrinsic properties of the target proteins.
The structures of in vivo aggregated proteins have been
analyzed by Fourier transform infrared (FT-IR) spectroscopy,
X-ray di¡raction, electron microscopy (EM), and solid-state
nuclear magnetic resonance (NMR). The spectroscopic tech-
niques are in wide use for L-amyloid, in which cross L-struc-
tures lead to formation of an insoluble ¢lament (FT-IR [22],
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X-ray [23], EM [24], liquid NMR [25], solid-state NMR [26]) ;
however, fewer approaches have been applied to inclusion
bodies because of their heterogeneous structures. For the het-
erogeneous aggregates, FT-IR spectroscopy is often used to
analyze the secondary structure, using the bands correspond-
ing to amide bond stretching [7,9,22]. The FT-IR spectrum of
interleukin (IL)-1L (which has only L-sheets in its native form)
in inclusion bodies shows a structure rich in L-structures, and
deconvolution analysis suggests that the composition of sec-
ondary structure is similar in the inclusion body and the na-
tive form [9]. In contrast, IL-2 and L-lactamase, both of which
have more than 50% K-helix in the native secondary structure,
have non-native L-structure in inclusion bodies as well as de-
creased K-helix content [7,27]. In general, the renaturation of
recombinant proteins from inclusion bodies is performed after
the solubilization by strong denaturant agents or detergents
which are considered to cause complete denaturation [16,28].
Complete denatured proteins, however, should be subjected to
complicated refolding procedures for blockading many o¡-
pathways to aggregation. The structural analysis for inclusion
bodies would be of importance, particularly when the refold-
ing of the proteins from inclusion bodies is attempted on the
basis of structural properties of the aggregated proteins.
In this study, we analyzed the structures of several recombi-
nant proteins in inclusion bodies expressed in Escherichia coli :
the L-sheet-rich single chain Fv (scFv) fragment from a mouse
anti-lysozyme monoclonal antibody (HyHEL-10), IL-4 with
more than 50% K-helix structure, and several K-helix-rich re-
combinant proteins from the hyperthermophilic archaeon Py-
rococcus horikoshii OT3. The hyperthermophilic archaeons are
one of the major target species for structural genomics [4,5],
but the hyperthermophilic proteins are frequently expressed as
inclusion bodies in E. coli [3,4], due to the di¡erence in the
optimal temperature for growth between host cell and hyper-
thermophilic archaeon. Secondary structure in inclusion
bodies was measured by FT-IR and solid-state NMR spec-
troscopy, and the solubilized form from inclusion bodies was
estimated from circular dichroism (CD) spectra. On the basis
of results obtained, we show that the hyperthermophilic pro-
tein forms rigid native-like secondary structure in inclusion
bodies. In addition, some of the hyperthermophilic proteins
in inclusion bodies could be solubilized without the degener-
ation of the secondary structure formed in inclusion bodies by
a 2 M guanidine hydrochloride (GdnHCl) solution, and fur-
ther, the solubilized proteins could be refolded by removal of
the denaturant via the stepwise dialysis method. We would
discuss the potential for the direct refolding from inclusion
bodies, not through complete denatured form.
2. Materials and methods
2.1. Materials
Lyophilized powdered bovine serum albumin (BSA) was purchased
from Wako Pure Chemical (Osaka, Japan). A plasmid containing
DNA coding for scFv of a mouse anti-lysozyme monoclonal anti-
body, HyHEL-10 (VL-linker-VH-(His)6), was constructed by inserting
the NcoI^XbaI fragment of pUTN3 [29] into the NcoI^XbaI-digested
plasmid pUT7 [30]. The gene for IL-4 was completely synthesized
from several oligonucleotides by an overlap extension polymerase
chain reaction (PCR) method as described previously [31], and the
full-length DNA was inserted into a T7 promoter-based pUT vector
after digestion with NcoI and SacII. The genes coding for PH0628,
PH0979, and PH1830, which have sequences homologous to methio-
nine aminopeptidase, hydrogenase, and glyceraldehyde-3-phosphate
dehydrogenase, respectively, in the hyperthermophilic archaeon
P. horikoshii OT3 [32], were ampli¢ed by PCR and then inserted
into pET15b after digestion with NdeI and BamHI. These hyperther-
mophilic proteins were selected because of their high expression as
inclusion bodies (more than 50% of the total expressed protein).
E. coli BL21(DE3) cells transformed with each expression vector
[33] were incubated in 2U YT medium at 28‡C, and expression of
each protein was induced by adding 1 mM isopropyl L-D-thiogalacto-
pyranoside (IPTG). The harvested cells were centrifuged and sus-
pended in 50 mM Tris^HCl (pH 8.0) bu¡er containing 200 mM
NaCl. The suspension was sonicated and then centrifuged at
5800Ug for 30 min at 4‡C. The supernatant was used to prepare
soluble recombinant proteins and the pellet to prepare inclusion
bodies.
To prepare native soluble hyperthermophilic proteins coded by
PH0628, PH0979, and PH1830, the supernatants were subjected to
immobilized metal a⁄nity chromatography (IMAC) on His-bind resin
(Novagen) and gel ¢ltration column chromatography on Superdex 75
(Amersham Biosciences, Tokyo, Japan).
To purify inclusion bodies, the suspension of the pellet in a 4%
Triton X-100 solution (50 mM Tris^HCl, 20 mM NaCl, pH 8.0)
and centrifugation (5800Ug for 30 min at 4‡C) were repeated several
times, and then the inclusion bodies were washed in water to remove
the detergent. Sodium dodecyl sulfate^polyacrylamide gel electropho-
resis indicated that the inclusion bodies consisted mainly of expressed
protein (more than 90% of all the proteins stained by Coomassie
brilliant blue R-250). For the FT-IR experiments, the wet inclusion
body pellet was dried under vacuum and then mixed with about 5%
(w/w) KBr.
The soluble forms of scFv and IL-4 were obtained from inclusion
bodies by refolding as described previously [34]. That is, the dena-
tured, reduced proteins in inclusion bodies were solubilized with a 6 M
GdnHCl solution containing 2-mercaptoethanol. The proteins were
then refolded by gradually removing GdnHCl with stepwise dialysis
from 6 to 3, 2, 1, 0.5 M, and ¢nally 0 M. L-Arginine (¢nal concen-
tration, 0.4 M) was added at the 1 and 0.5 M GdnHCl stages. Redox
reagent (oxidized form of glutathione for scFv, a mixture of oxidized
and reduced form of glutathione for IL-4) was also introduced at the
same stages (¢nal concentration, 50-fold molar excess relative to the
protein concentration).
2.2. Refolding of hyperthermophilic protein from inclusion bodies
Each inclusion body was solubilized by a 2 M GdnHCl solution (50
mM Tris^HCl, 20 mM NaCl, pH 8.0), and then the solutions were
puri¢ed by IMAC and gel ¢ltration column chromatography on
Superdex 75. The solubilized hyperthermophilic proteins were re-
folded by removing GdnHCl with dialysis from 2 M GdnHCl to
0 M; The PH0979-coded protein solution was directly dialyzed
from 2 to 0 M, while the PH0628- and PH1830-coded proteins were
refolded by stepwise dialysis through 1 and 0.5 M GdnHCl solutions
containing 0.4 M L-arginine.
2.3. FT-IR and solid-state NMR experiments
Di¡use re£ectance FT-IR spectra were obtained with an FTS-165
(Bio-Rad Lab., USA), scanned 3000 times at a resolution of 2 cm31.
Solid-state NMR spectra were collected at room temperature with a
Bruker DRX-400 spectrometer equipped with a 4 mm double reso-
nance probe. The magic angle spinning (MAS) technique was applied
at frequencies of 8 kHz. Two-pulse phase modulation was used for
proton decoupling, with pulses of 8 Ws alternating between two phases
separated by an angle of 15‡ [35]. A cross polarization (CP) sequence
with a linear ramp from 100 to 70% was applied for the heteronuclear
1H-13C polarization transfer at high MAS rates during a CP time of
2^4 ms [36].
The two-dimensional (2D) homonuclear 13C-13C dipolar correlation
spectra were measured by the proton-driven spin di¡usion (PDSD)
technique [37] and were collected with time-proportional phase incre-
mentation. The 2D homonuclear 13C spectra were collected for 256 t1
data points and 1024 t2 data points, and 256 scans were collected for
each t1 point using a repetition time of 1 s.
For the 2D NMR spectra, the proteins in inclusion bodies were
fully or selectively 13C labeled. For the fully 13C-labeled proteins,
transformed E. coli cells were grown at 28‡C in a minimal medium
based on M9 medium containing 1 g l31 of fully 13C-labeled D-glucose
(Isotec, USA). The selectively labeled proteins were produced based
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on the method of Muchmore et al. [38] and amino acid metabolism
[39]: 2 ml of an amino acid blend containing 1.5% (w/v) each of
asparagine, aspartic acid, methionine, threonine, lysine, isoleucine,
glutamic acid, glutamine, proline, and arginine was added to 1 l of
cells growing in M9 medium containing 1 g of fully 13C-labeled D-
glucose. In the modi¢ed M9 medium, the carbons in glycine, alanine,
valine, leucine, serine, cysteine, tryptophan, phenylalanine, tyrosine,
and histidine should become fully labeled.
2.4. CD spectra
CD spectra were measured with an AVIV CD spectrometer (Pro-
teiron Co., USA): path length, 1.0 mm; resolution, 0.2 nm; average
time, 4 s. Recombinant proteins in inclusion bodies were solubilized in
50 mM Tris^HCl (pH 8.0) bu¡er containing 0.5% cetyltrimethylam-
monium chloride (CTAC) and 200 mM NaCl. The solubilized pro-
teins were puri¢ed by IMAC followed by gel ¢ltration column chro-
matography.
3. Results
3.1. FT-IR and solid-state NMR spectra
Fig. 1 shows the FT-IR spectra in the amide I region for
lyophilized BSA powder (a) and for inclusion bodies contain-
ing scFv (b), IL-4 (c), and PH0979-coded protein (d). The IR
spectrum for BSA showed a maximum at 1659 cm31 (Fig. 1a),
but that for scFv did not show an explicit maximum, due to
an increased intensity around 1630 cm31 (Fig. 1b). According
to previous reports [9,40,41], the amide I band at 1650^1660
cm31 can be assigned to an K-helix or an irregular loop struc-
ture, and the bands around 1620^1630 cm31 are assigned to
L-structures. The spectrum for inclusion bodies of IL-4
showed a maximum at 1687 cm31 rather than at 1659 cm31,
and amide I bands corresponding to L-structures appeared
around 1630 cm31 (Fig. 1c). Considering the native structure
of IL-4 as determined by NMR analysis (55% K-helix and 3%
L-structure) [42], the relative amount of L-structure seems
higher in the in vivo aggregated IL-4. In contrast, the
PH0979-coded hyperthermophilic protein (Fig. 1d), whose na-
tive structure from the soluble fraction is 42% K-helix as de-
termined by CD spectroscopy (see Fig. 5d), showed a predom-
inant amide I band at 1660 cm31 (similar to BSA), without
any bands clearly attributable to L-structure. Similar results
were obtained for the other hyperthermophilic proteins
(PH0628 and PH1830, data not shown).
Solid-state 13C CP/MAS NMR spectra were measured in
the region of carbonyl carbon resonance, to recognize K-helix
structures (Fig. 2), because it is di⁄cult to discern solely from
IR spectra whether the band at 1650^1660 cm31 arises from
K-helix or irregular/loop structures. The NMR spectrum of
BSA had a maximum at 175.5 ppm, which is assigned to K-
helix structure (Fig. 2a) [43,44], implying that the amide I
band at 1659 cm31 in the FT-IR spectrum can also be attrib-
uted to K-helix structure. For scFv, resonance was enhanced
at 173 ppm, but the intensity at 175^176 ppm decreased rel-
ative to the BSA spectra (Fig. 2b), indicating that the FT-IR
spectrum for scFv has little of the component corresponding
to K-helix structure. The NMR spectra for the other proteins
(IL-4 and PH0979, Fig. 2c and d; PH0628 and PH1830, data
not shown) showed a clear shoulder at 176 ppm; therefore,
the corresponding FT-IR spectra indicate the presence of
K-helix structure. The inclusion bodies used for the FT-IR
measurement were dried and mixed with KBr, which might
induce the structural change of protein. On the other hand, we
measured the solid-state NMR spectra for the dried and hy-
drate inclusion bodies (dried sample: data not shown, hydrate
sample: Fig. 2) and recognized the identical spectra between
them for all the proteins. This indicates that the K-helix struc-
Fig. 1. FT-IR spectra in the amide I region for (a) lyophilized pow-
dered BSA, and for inclusion bodies containing (b) scFv, (c) IL-4,
and (d) PH0979-coded protein.
Fig. 2. Solid-state 13C CP/MAS NMR spectra in the region of car-
bonyl carbon for (a) lyophilized powdered BSA, and for inclusion
bodies containing (b) scFv, (c) IL-4, and (d) PH0979-coded protein.
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ture observed in the inclusion bodies is not changed by the
treatment by dehydration.
We also measured the 2D homonuclear 13C-13C dipolar
correlation NMR spectrum, which also detects K-helix struc-
ture. Fig. 3 shows a contour plot of the 2D 13C-13C spectra of
fully 13C-labeled scFv (a) and amino-selective labeled scFv
(b). Both spectra are much less re¢ned than 2D NMR results
reported for optimized proteins in solid-state NMR experi-
ments [45], indicating much heterogeneity in the inclusion
body. The contour plot for the fully labeled scFv shows clear
correlation signals between CK, CL, and CQ for threonine (sol-
id circles in Fig. 3a) and a cross peak from CQ /CN in isoleucine
(dashed circles in Fig. 3a). However, the 2D spectrum for the
selectively labeled scFv completely showed no correlation
from threonine or isoleucine (Fig. 3b). The correlation be-
tween the resonances at 58 and 19 ppm (dotted circle in
Fig. 3. Contour plot of the 2D CP/MAS PDSD 13C-13C dipolar correlation spectra for (a) uniformly 13C-labeled scFv and (b) amino-selective
labeled scFv in inclusion bodies at a magnetic ¢eld of 9.5 T. The MAS rotation frequency and the mixing time were 8 kHz and 15 ms, respec-
tively. The solid and dashed circles indicate correlations between CK, CL, and CQ in threonine and between CQ and CN in isoleucine, respec-
tively. The dotted circle represents the correlation derived from valine (see 2D NMR in Section 3).
Fig. 4. Contour plot of 2D CP/MAS PDSD 13C-13C dipolar correlation spectra for amino-selective 13C-labeled (a) scFv and (b) PH0979-coded
protein in inclusion bodies at a magnetic ¢eld of 9.5 T. The MAS rotation frequency and the mixing time were 8 kHz and 15 ms, respectively.
The solid and dotted lines indicate the two types of correlation between CK, CL, and CQ in valine.
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Fig. 3a) may be assigned to a transfer of coherence between
CK and CQ in threonine or valine but the observation of the
cross peak in the contour plot for the selectively labeled scFv
(dotted circle in Fig. 3b) proves that the correlation is derived
from valine.
Fig. 4 shows the 13C-13C dipolar correlation spectrum for
the amino-selective labeled scFv (a) and the PH0979-coded
hyperthermophilic protein (b). In the spectrum for selectively
labeled scFv (Fig. 4a), CK in valine is resonated at 58 ppm and
makes a clear cross peak with CL and CQ of valine at 32 and
19 ppm, respectively (solid line). A similar correlation network
in valine also occurred in the spectrum for the PH0979-coded
protein (solid line in Fig. 4b), but another correlation corre-
sponding to valine was also observed (dotted line in Fig. 4b);
in this new network, CK in valine at 64 ppm makes a corre-
lation with CL and CQ of valine at 30 and 20 ppm. Consider-
ing that the chemical shift for CK of valine in an K-helix
structure is signi¢cantly down¢eld shifted from the standard
value (60^61 ppm) to V65 ppm [44], the chemical shift at 64
ppm observed only for PH0979-coded protein can be assigned
to the CK of valine in an K-helix structure. These 2D NMR
results suggest no K-helix structure in the in vivo aggregated
scFv and support that PH0979-coded protein forms an K-helix
structure in inclusion bodies.
3.2. CD spectra of native proteins and those solubilized from
inclusion bodies by CTAC
Fig. 5 shows the CD spectra for each protein in its native
form (solid line) and after solubilization by CTAC (dotted
line) from a lyophilized powder (BSA) or from inclusion
bodies (the recombinant proteins). BSA showed a typical
spectrum for an K-helix structure, with strong intensity at
222 nm (solid line, Fig. 5a); however, the intensity at 222
nm for BSA in 0.5% CTAC was lower (dotted line in Fig.
5a). Thus, CTAC detergent denatured BSA to some extent.
For scFv and IL-4, the spectra of the solubilized forms dif-
fered from those of the native structures (Fig. 5b,c). The na-
tive structure of scFv showed a clear trough at 218 nm, which
can be attributed to L-structure (solid line in Fig. 5b), but a
trough at 205 nm appears with the decrease of the CD inten-
sity at 218 nm for the solubilized form (dotted line in Fig. 5b).
The solubilized form of IL-4 had a much weaker trough at
222 nm than the native form, and the trough at 208 nm for
the native form was shifted to 205 nm for the solubilized form
(Fig. 5c). The PH0979-coded hyperthermophilic protein had
the same intensity at 222 nm as its native structure, although
the trough at 208 nm was slightly enhanced (Fig. 5d). Con-
servation of the 222 nm CD intensity was observed also for
the other hyperthermophilic proteins (PH0628 and PH1830,
data not shown), suggesting that the solubilized forms of the
hyperthermophilic proteins have a rigid native-like K-helix
structure. The slight enhancement at 208 nm was also ob-
served for the PH0628-coded protein (data not shown). This
might imply the existence of partially non-native structures in
addition to the native-like K-helix structure.
3.3. Refolding of hyperthermophilic protein from inclusion
bodies without complete denaturation
We also measured the CD spectra for the recombinant pro-
teins solubilized from inclusion bodies by a 2 M GdnHCl
solution (Fig. 6a). The solubilized scFv and IL-4 showed no
characteristic CD signals derived from secondary structure
(data not shown), while the CD spectrum for the solubilized
PH0979-coded protein had a large trough at 222 nm (dotted
line in Fig. 6a). Although the CD spectrum in the region of
200^212 nm was not measured in the 2 M GdnHCl solution
due to high concentration of GdnHCl, the comparable CD
intensity of the solubilized form to that of native form at 222
nm indicates that the K-helix structure formed in inclusion
bodies has higher tolerance for chaotropic agent than the sec-
ondary structure of scFv and IL-4 (Fig. 6a). This suggests that
the PH0979-coded proteins in inclusion bodies were solubi-
lized by 2 M GdnHCl solution with the rigid native-like
K-helix structure conserved. For the attempt to refold the
PH0979-coded protein from the solubilized form without
complete denaturation, GdnHCl was removed from the solu-
bilizing solution by direct dialysis to a GdnHCl-free solution.
The simple removal of GdnHCl attained the refolding yield of
75% for the PH0979-coded protein, and 67% of the refolded
Fig. 5. CD spectra of (a) BSA, (b) scFv, (c) IL-4, and (d) PH0979-
coded protein in native and refolded forms (solid line), and solubi-
lized form by CTAC detergent (dotted line). Lyophilized BSA was
directly dissolved in 50 mM Tris^HCl (pH 8.0), 200 mM NaCl,
1 mM ethylenediamine tetraacetic acid (EDTA) (solid line) or in
Tris^HCl bu¡er with 0.5% CTAC detergent (dotted line). For scFv
and IL-4, the protein that was refolded from inclusion bodies by
stepwise dialysis (see Section 2) was measured in the Tris^HCl bu¡-
er lacking CTAC detergent (solid lines in b, c), and the native form
of PH0979-coded protein was obtained from a soluble cytoplasmic
fraction (solid line in d). The solubilized forms (scFv, IL-4, and
PH0979-coded protein) were extracted from inclusion bodies by
0.5% CTAC solution and were measured in Tris^HCl bu¡er with
0.5% CTAC detergent after puri¢cation by IMAC and gel ¢ltration
(dotted lines in b^d).
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proteins was thermostable (Table 1). The refolded PH0979-
coded protein showed the identical CD pro¢le to that of na-
tive protein (Fig. 6b), which has the same troughs at 222 and
208 nm as those of native form. This result supports the
suggestion that PH0979-coded protein forms the native-like
secondary structure in inclusion bodies.
The PH0628- and PH1830-coded proteins were also solubi-
lized by 2 M GdnHCl solution, and native-like CD signals
were recognized for both the solubilized proteins (data not
shown); however, most of proteins were aggregated by the
direct dialysis from 2 M GdnHCl to 0 M. We also attempted
to refold the solubilized PH0628- and PH1830-coded proteins
by the stepwise dialysis trough 1 and 0.5 M GdnHCl solutions
containing 0.4 M L-arginine. The modest refolding procedure
raised the refolding yield up to 62% (PH0628) and 43%
(PH1830), and about half of the refolded proteins were ther-
mostable (Table 1). As the case of PH0979-coded protein, CD
spectra of these two proteins refolded were identical to those
of native proteins (data not shown).
4. Discussion
In this study, we measured FT-IR and solid-state NMR
spectra for several recombinant proteins in inclusion bodies
and found secondary structural di¡erences between proteins.
All our recombinant proteins had substantial secondary struc-
tures in inclusion bodies, but the degree of similarity to native
structures seemed to vary; scFv and IL-4 in inclusion bodies
seemed to have non-native structure, while the secondary
structure of K-helix-rich hyperthermophilic proteins used in
this study was native-like even in the dried inclusion bodies
(Fig. 1). The solid-state NMR spectra for the dried and hy-
drated inclusion bodies were identical (Fig. 2), indicating that
the secondary structures of the proteins in inclusion bodies are
too rigid to be a¡ected by the dehydration treatment which
might have had the potential to change the secondary struc-
ture. Fink et al. [7] reported that aggregation often leads to an
increase of the secondary structure indicated by the amide I
components around 1630 cm31 in IR spectra, suggesting that
the intermolecular interaction leading to aggregation involves
L-sheet-like interactions. The formation of non-native L-struc-
tures in inclusion bodies has been observed for IL-2 and L-lac-
tamase, which have 57 and 32% K-helix structure, respectively,
in their native forms [7,27]. The same result seems to be ob-
served for IL-4, but the hyperthermophilic recombinant pro-
teins in inclusion bodies have K-helix-rich structure with little
amide I components around 1630 cm31 observed (Fig. 1).
This indicates that the hyperthermophilic proteins are aggre-
gated in vivo after the formation of the secondary structure
and that the secondary structure, especially K-helix, is not
changed by the aggregation. Interestingly, the K-helix struc-
tures were so rigid that a detergent, CTAC, and low concen-
trated GdnHCl denaturant cannot denature the secondary
structure of the proteins (Figs. 5d, 6a), and further the far-
ultraviolet (UV) CD properties were comparable to those of
native form. The solubilization of native-like secondary struc-
ture from inclusion bodies supports the observation of the
native-like structure in inclusion bodies and the suggestion
that the structure can not be changed by in vivo aggregation.
The formation of inclusion bodies has been reported for
P22 tailspike endorhamnosidase [46,47] and human IL-1L
[48]. The aggregation behavior of P22 tailspike protein indi-
cates that a thermolabile intermediate formed during folding
in vivo leads to the formation of inclusion bodies [8,46,47],
and the formation of inclusion bodies of IL-1L has also been
explained in terms of the properties of a folding intermediate
rather than those of the native state [48^50]. For the hyper-
thermophilic proteins, therefore, the formation of inclusion
bodies might be originated from non-native association be-
tween secondary structure elements.
In general, the recombinant proteins in inclusion bodies are
solubilized by a high concentrated strong denaturant, such as
6 M GdnHCl or 9 M urea, and refolded by removal of the
denaturants via dilution or dialysis [16,28]. The refolding from
Fig. 6. a: CD spectra of PH0979-coded protein in native form (solid
line) and solubilized form by 2 M GdnHCl (dotted line). The solu-
bilized PH0979-coded protein was extracted from inclusion bodies
by 2 M GdnHCl and was measured in Tris^HCl bu¡er with 2 M
GdnHCl after puri¢cation by IMAC and gel ¢ltration. b: CD spec-
tra of PH0979-coded protein in native form (solid line) and refolded
form (dotted line). The refolded form was measured after the solu-
bilization from inclusion bodies by 2 M GdnHCl and removal of
GdnHCl by dialysis to GdnHCl-free Tris^HCl bu¡er. The concen-
trations of native and refolded forms were 4 and 0.8 WM, respec-
tively.
Table 1
The refolding ratio of the hyperthermophilic protein from inclusion
bodies without complete denaturation
Refolding ratio (%)a After heat treatment (%)b
PH0628 62c 42
PH0979 75d 67
PH1830 43c 69
aEach recombinant protein was solubilized from inclusion bodies by
2 M GdnHCl and puri¢ed by IMAC and gel ¢ltration, and then
the protein^GdnHCl solutions were dialyzed to GdnHCl-free solu-
tion.
bEach refolded protein was heated at 70‡C for 30 min. The ratios
were calculated by dividing the amount of the soluble proteins after
the heat treatment by the total amount of the refolded protein.
cPH0628- and PH1830-coded proteins were refolded by the stepwise
dialysis to a simple Tris^HCl solution through the 1 and 0.5 M
GdnHCl solutions containing 0.4 M L-arginine.
dPH0970-coded protein was refolded by direct dialysis to a simple
Tris^HCl solution.
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completely denatured form is frequently di⁄cult to attain
highly e⁄cient yield due to the competing o¡-pathway self-
association of the folding intermediates in the refolding in
vitro [15]. Especially, the denaturation of hyperthermophilic
protein is apt to be irreversible perhaps because the relaxation
kinetics of folding^unfolding is unusual slow [51,52] ; indeed,
to our knowledge, completely denatured hyperthermophilic
proteins are not often refolded by frequently used methods
(M. Umetsu and K. Tsumoto, unpublished data). The fact
that the PH0979-coded proteins were refolded from the inclu-
sion bodies with 2 M GdnHCl supports the existence of na-
tive-like secondary structure in inclusion bodies, but also pro-
poses a new refolding procedure from the inclusion bodies
which can be a cross-cut from aggregated form in inclusion
bodies of archaeon proteins to a native form. Recently, we
solubilized green £uorescent protein (GFP) from the inclusion
bodies expressed in E. coli using a low concentrated GdnHCl
and L-arginine; the solubilized GFP protein is £uorescent
even in the solubilizing solutions, and the GFP protein after
the removal of the denaturants attains identical activity to
native form [53]. In this study, we could refold the hyperther-
mophilic proteins from in vivo aggregates without complete
denaturation, but the refolding yields were di¡erent between
the proteins used; half of the solubilized PH0979-coded pro-
tein was refolded to a thermostable form by a direct dialysis
to a GdnHCl-free solution (Table 1), while most of the
PH0628- and PH1830-coded proteins were aggregated by
the dialysis (data not shown). Gradual removal of the dena-
turant via stepwise dialysis increased the refolding yield (Table
1), indicating the importance of promoting the appropriate
association between the secondary structure elements for re-
folding to native form. According to our gel ¢ltration of the
native forms, the PH0979-coded protein is in monomeric form
while the PH0628- and PH1830-coded proteins are in dimeric
and tetrameric forms, respectively. The refolded and thermo-
stable proteins also showed the identical oligomerization (data
not shown). The refolding yield might be in£uenced by the
variation of the association between each polypeptide chain.
In conclusion, the recombinant thermostable proteins from
hyperthermophilic archaeon in inclusion bodies had native-
like rigid secondary structures. The refolding of the hyper-
thermophilic proteins from the aggregated forms in inclusion
bodies could be accomplished by solubilization with lower
concentration of GdnHCl and removal of the denaturant,
indicating the importance of promoting appropriate associa-
tion between the secondary structure elements.
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